CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 126 enrolled
Drug / intervention
distal protection and thrombus aspiration (The GuardWire Plus (Medtronic Inc.)) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01384019
NCT01384019Phase 4Completed
CompareCT.gov

Distal Protection Device Did Not Improve Microvascular Obstruction Evaluated by Cardiac MR After Primary Percutaneous Intervention for ST-elevation Myocardial Infarction

Seoul National University Bundang Hospital·interventional·Posted Jun 28, 2011·Updated Mar 18, 2013

In Brief

A Phase 4 clinical trial evaluating distal protection and thrombus aspiration (The GuardWire Plus (Medtronic Inc.)) and c-PCI for ST-segment Elevation Myocardial Infarction. Completed, enrolled 126 participants across 1 site.

Detailed Summary

The investigators examined the mechanism underlying the lack of benefit from distal protection and thrombus aspiration (DP-TA) in 126 patients with ST-elevation Myocardial Infarction (STEMI) in a prospective, randomized trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsST-segment Elevation Myocardial Infarction
CountriesSouth Korea
Collaborators--

Timeline

Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 28, 2011
Enrollment StartJan 1, 2004
Primary CompletionJun 1, 2008
Study CompletionAug 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 15.0 years ago

Interventions

distal protection and thrombus aspiration (The GuardWire Plus (Medtronic Inc.))device

The GuardWire Plus (Medtronic Inc.): distal balloon occlusion and proximal thrombus aspiration

c-PCIprocedure

conventional PCI without Guard wire